Regeneron Pharmaceuticals | REGN - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals reported $601.1M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
AbbVie ABBV:US USD 3B 217M
Agenus AGEN:US USD 18.24M 6.8M
Agios Pharmaceuticals AGIO:US USD 28.37M 4.4M
Alimera Sciences ALIM:US USD 9.98M 876K
Alnylam Pharmaceuticals ALNY:US USD 183.66M 26.68M
Amgen AMGN:US USD 1.26B 210M
Astellas Pharma 4503:JP JPY 159.3B 3.73B
AstraZeneca AZN:LN USD 3.2B 331M
Biogen BIIB:US USD 605M 27.8M
BioMarin Pharmaceutical BMRN:US USD 223M 22.74M
Bluebird Bio BLUE:US USD 37.35M 6.65M
Bristol-Myers Squibb BMY:US USD 1.76B 504M
Eli Lilly LLY:US USD 1.75B 106M
Esperion Therapeutics ESPR:US USD 29.9M 5.76M
Gilead Sciences GILD:US USD 1.32B 702M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Incyte Corp INCY:US USD 315.61M 42.79M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
Ionis Pharmaceuticals IONS:US USD 45.52M 2.43M
Iveric bio Inc. OPHT:US USD 31.76M 4.63M
J&J JNJ:US USD 6.14B 374M
Kyowa Hakko Kirin 4151:JP JPY 39.33B 7.1B
Merck & Co MRK:US USD 2.46B 209M
Moderna Inc MRNA:US USD 305M 70M
Neurocrine Biosciences NBIX:US USD 242.7M 59.8M
Novartis NOVN:VX USD 3.4B 298M
Novartis NVS:US USD 3.4B 298M
Opthea Ltd OPT:AU USD 17.49M 945.17K
Pfizer PFE:US USD 3.49B 1.39B
Puma Biotechnology PBYI:US USD 22.49M 2.55M
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Roche Holding ROG:VX CHF 6.48B 834M
Sarepta Therapeutics SRPT:US USD 110.71M 9.76M
Seattle Genetics SGEN:US USD 206.44M 9.66M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 842M 5M
Ultragenyx Pharmaceutical RARE:US USD 76.65M 3.8M
United Therapeutics UTHR:US USD 87.3M 64.7M
Vertex Pharmaceuticals VRTX:US USD 241.1M 26.3M